Acrivon Therapeutics Inc.... (ACRV)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

7.06

-0.28%

After-hours Dec 13, 2024, 04:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20
Revenue	-	-	-	-
Cost of Revenue	536.00K	1.09M	832.00K	13.00K
Gross Profit	-536.00K	-1.09M	-832.00K	-13.00K
Operating Income	-67.24M	-32.66M	-16.18M	-3.17M
Interest Income	-	-	-	-
Pretax Income	-60.39M	-31.17M	-16.24M	-5.31M
Net Income	-60.39M	-29.68M	-16.24M	-5.31M
Selling & General & Admin	21.21M	8.71M	2.47M	1.30M
Research & Development	45.49M	23.95M	13.72M	1.87M
Other Expenses	-	1.49M	-59.00K	-2.14M
Operating Expenses	66.70M	32.66M	16.18M	3.17M
Interest Expense	-	-	-	-
Selling & Marketing Expenses	134.00K	-	-	-
Cost & Expenses	67.24M	32.66M	16.18M	3.17M
Income Tax	-	-1.49M	-199.56K	-193.30K
Shares Outstanding (Basic)	22.08M	21.92M	20.86M	20.86M
Shares Outstanding (Diluted)	22.08M	21.92M	20.86M	20.86M
EPS (Basic)	-2.74	-1.35	-0.78	-0.25
EPS (Diluted)	-2.74	-1.35	-0.78	-0.25
EBITDA	-59.85M	-30.07M	-15.41M	-5.29M
Depreciation & Amortization	536.00K	1.09M	832.00K	13.00K